566 related articles for article (PubMed ID: 12297910)
21. Patterns of early recurrence after sentinel lymph node biopsy for melanoma.
Chao C; Wong SL; Ross MI; Reintgen DS; Noyes RD; Cerrito PB; Edwards MJ; McMasters KM;
Am J Surg; 2002 Dec; 184(6):520-4; discussion 525. PubMed ID: 12488154
[TBL] [Abstract][Full Text] [Related]
22. Standard and nonstandard applications of sentinel node-guided melanoma surgery.
Schachter J; Laish A; Mekhmandarov S; Feinmesser M; Fenig E; Tamir G; Gutman H
World J Surg; 2000 Apr; 24(4):491-4; discussion 494-5. PubMed ID: 10706925
[TBL] [Abstract][Full Text] [Related]
23. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
24. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
25. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up.
Statius Muller MG; Borgstein PJ; Pijpers R; van Leeuwen PA; van Diest PJ; Gupta A; Meijer S
Ann Surg Oncol; 2000 Jul; 7(6):461-8. PubMed ID: 10894143
[TBL] [Abstract][Full Text] [Related]
26. Predictors and patterns of melanoma recurrence following a negative sentinel lymph node biopsy.
O'Connell EP; O'Leary DP; Fogarty K; Khan ZJ; Redmond HP
Melanoma Res; 2016 Feb; 26(1):66-70. PubMed ID: 26460498
[TBL] [Abstract][Full Text] [Related]
27. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
[TBL] [Abstract][Full Text] [Related]
29. Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?
Yao KA; Hsueh EC; Essner R; Foshag LJ; Wanek LA; Morton DL
Ann Surg; 2003 Nov; 238(5):743-7. PubMed ID: 14578738
[TBL] [Abstract][Full Text] [Related]
30. Is there increased risk of local and in-transit recurrence following sentinel lymph node biopsy?
Cerovac S; Mashhadi SA; Williams AM; Allan RA; Stanley PR; Powell BW
J Plast Reconstr Aesthet Surg; 2006; 59(5):487-93. PubMed ID: 16631558
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
32. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
[TBL] [Abstract][Full Text] [Related]
35. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
36. Patterns of drainage and recurrence following sentinel lymph node biopsy for cutaneous melanoma of the head and neck.
Fincher TR; O'Brien JC; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; Kuhn JA
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):844-8. PubMed ID: 15262761
[TBL] [Abstract][Full Text] [Related]
37. Outcome of patients with melanoma and histologically negative sentinel lymph nodes.
Gadd MA; Cosimi AB; Yu J; Duncan LM; Yu L; Flotte TJ; Souba WW; Ott MJ; Wong LS; Sober AJ; Mihm MC; Haluska FG; Tanabe KK
Arch Surg; 1999 Apr; 134(4):381-7. PubMed ID: 10199310
[TBL] [Abstract][Full Text] [Related]
38. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
[TBL] [Abstract][Full Text] [Related]
40. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
